Canaccord raised the firm’s price target on Xencor to $38 from $36 and keeps a Buy rating on the shares. The firm noted the company has multiple upcoming data catalysts planned for 2024, which they think will continue to build conviction for its T-cell engager platform.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on XNCR:
